早期妊娠与妊娠中期血浆氨基酸及其与磷脂脂肪酸的交互作用与妊娠期糖尿病风险的关系:纵向前瞻性队列研究结果
基于2802人纵向妊娠队列,在107例妊娠期糖尿病(GDM)病例与214例非GDM对照中检测妊娠10-14周和15-26周24种血浆氨基酸。早期妊娠甘氨酸与GDM风险呈负相关,丙氨酸、天冬氨酸、谷氨酸呈正相关;妊娠中期异亮氨酸、苯丙氨酸、酪氨酸呈正相关。氨基酸与磷脂脂肪酸对GDM风险存在联合关联。
要点
- 妊娠10-14周甘氨酸每增加1个标准差,GDM调整OR为0.55(95%CI 0.39-0.79)。
- 妊娠10-14周丙氨酸、天冬氨酸与GDM呈正相关(OR分别为1.43、1.41)。
- 妊娠10-14周高甘氨酸且低偶数链饱和脂肪酸者GDM风险最低(调整OR 0.15)。
核心结论
- 血浆氨基酸可能从妊娠早期起即参与GDM的发生,氨基酸与GDM的关联在同时存在特定磷脂脂肪酸谱时可能增强。
研究设计与样本
- 纵向前瞻性妊娠队列,共2802人,纳入107例GDM病例与214例非GDM对照,检测妊娠10-14周和15-26周24种血浆氨基酸,并校正年龄、孕前BMI及糖尿病家族史等因素。
主要发现
- 妊娠10-14周甘氨酸每增加1个标准差,GDM调整OR为0.55(95%CI 0.39-0.79)。
- 妊娠10-14周丙氨酸、天冬氨酸、谷氨酸每增加1个标准差,GDM调整OR分别为1.43(95%CI 1.08-1.88)、1.41(95%CI 1.11-1.80)、1.39(95%CI 0.98-1.98)。
- 妊娠15-26周甘氨酸、丙氨酸、天冬氨酸及谷氨酰胺与谷氨酸比值的方向与妊娠10-14周一致。
- 妊娠15-26周异亮氨酸、苯丙氨酸、酪氨酸每增加1个标准差,GDM调整OR分别为1.64(95%CI 1.19-2.27)、1.15(95%CI 0.87-1.53)、1.56(95%CI 1.16-2.09)。
- 多种氨基酸与磷脂脂肪酸对GDM风险存在显著联合关联,妊娠10-14周高甘氨酸且低偶数链饱和脂肪酸者风险最低,调整OR为0.15(95%CI 0.06-0.37)。
关键数值与推荐
- 所有线性趋势P值<0.05。
- 妊娠10-14周甘氨酸每增加1个标准差,GDM调整OR为0.55(95%CI 0.39-0.79)。
- 妊娠10-14周丙氨酸每增加1个标准差,GDM调整OR为1.43(95%CI 1.08-1.88);天冬氨酸为1.41(95%CI 1.11-1.80);谷氨酸为1.39(95%CI 0.98-1.98)。
- 妊娠15-26周异亮氨酸每增加1个标准差,GDM调整OR为1.64(95%CI 1.19-2.27);苯丙氨酸为1.15(95%CI 0.87-1.53);酪氨酸为1.56(95%CI 1.16-2.09)。
- 妊娠10-14周高甘氨酸且低偶数链饱和脂肪酸者GDM调整OR为0.15(95%CI 0.06-0.37)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We prospectively evaluated plasma amino acids (AAs) in early pregnancy and midpregnancy and their interplay with phospholipid fatty acids (FAs) in association with gestational diabetes mellitus (GDM) risk. RESEARCH DESIGN AND METHODS: From a longitudinal pregnancy cohort of 2,802 individuals, concentrations of 24 plasma AAs at 10-14 and 15-26 gestational weeks (GW) were assessed among 107 GDM case subjects and 214 non-GDM control subjects. We estimated adjusted odds ratios (OR) and 95% CI for the associations of plasma AAs and the joint associations of plasma AAs and phospholipid FAs with GDM risk, adjusting for risk factors including age, prepregnancy BMI, and family history of diabetes. RESULTS: Glycine at 10-14 GW was inversely associated with GDM (adjusted OR [95% CI] per SD increment: 0.55 [0.39-0.79]). Alanine, aspartic acid, and glutamic acid at 10-14 GW were positively associated with GDM (1.43 [1.08-1.88], 1.41 [1.11-1.80], and 1.39 [0.98-1.98]). At 15-26 GW, findings for glycine, alanine, aspartic acid, and the glutamine-to-glutamic acid ratio were consistent with the directions observed at 10-14 GW. Isoleucine, phenylalanine, and tyrosine were positively associated with GDM (1.64 [1.19-2.27], 1.15 [0.87-1.53], and 1.56 [1.16-2.09]). All P values for linear trend were <0.05. Several AAs and phospholipid FAs were significantly and jointly associated with GDM. For instance, the lowest risk was observed among women with higher glycine and lower even-chain saturated FAs at 10-14 GW (adjusted OR [95% CI] 0.15 [0.06, 0.37]). CONCLUSIONS: Plasma AAs may be implicated in GDM development starting in early pregnancy. Associations of AAs with GDM may be enhanced in the copresence of phospholipid FA profile.
引用
- Yang J, Wu J, Tekola-Ayele F, et al. Plasma Amino Acids in Early Pregnancy and Midpregnancy and Their Interplay With Phospholipid Fatty Acids in Association With the Risk of Gestational Diabetes Mellitus: Results From a Longitudinal Prospective Cohort. Diabetes Care. 2023. PMID: 36701229. doi:10.2337/dc22-1892
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。